More recently, ACE inhibitor therapy in mice was established to abolish the release of spleen-derived monocytes into the circulation, resulting in lower inflammatory cell infiltration to the infarct territory after coronary artery occlusion [8]. Here, ACE is linked to arterial occlusion.